RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and

Daniël A Lionarons1, David C Hancock1, Sareena Rana2

  • 1Oncogene Biology, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Cancer Cell
|July 2, 2019
PubMed

Insights

The RAC1 P29S mutation promotes melanoma development and therapy resistance by activating specific pathways. Inhibiting the SRF/MRTF pathway can reverse resistance, offering a potential therapeutic strategy for melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RAC1 P29 is a frequent mutation in cutaneous melanoma.
  • Understanding RAC1's role is crucial for melanoma treatment.

Purpose of the Study:

  • Investigate the function of RAC1 P29S in melanoma.
  • Identify therapeutic targets for RAC1-driven melanoma.

Main Methods:

  • Studied RAC1 P29S in mouse models.
  • Analyzed gene expression and protein activation.
  • Assessed drug resistance mechanisms.

Main Results:

  • RAC1 P29S activates PAK, AKT, and SRF/MRTF pathways.
  • This leads to a melanocytic to mesenchymal transition.
  • RAC1 P29S drives melanoma initiation and BRAF inhibitor resistance.
  • Resistance is reversed by SRF/MRTF inhibitors.

Conclusions:

  • RAC1 P29S is a key driver of melanoma initiation.
  • It mediates resistance to BRAF inhibitors.
  • SRF/MRTF pathway is a potential therapeutic target in melanoma.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.4K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Switching of BJT01:22

Switching of BJT

Switching behavior in Bipolar Junction Transistors (BJTs) is a fundamental aspect utilized in various electronic circuits, particularly for digital logic applications like switches and amplifiers. In a typical switching circuit, a BJT alternates between cut-off and saturation modes, corresponding to the "off" and "on" states, respectively, thus behaving like an ideal switch.
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
812
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K